CAMK2G and Alzheimer disease: The role of NF-κB in AD was recently covered more broadly in a dedicated review (6) which discussed the regulation of NF-κB by Aβ as well as giving a comprehensive overview of NF-κB targets with potential implications in AD development or cognitive symptoms, including CREB, MnSOD, CAMKII, and PSD95.